Overview of Mucormycosis Cases in Türkiye: A Cumulative Case Analysis.

backgroundMucormycosis is a life-threatening angioinvasive fungal infection that primarily affects immunocompromised individuals, especially those with diabetes mellitus or hematologic malignancies. Despite its clinical importance, a comprehensive synthesis of mucormycosis cases from Türkiye is lacking. This study aimed to review and synthesize the published case reports on mucormycosis in Türkiye systematically. MATERIALS AND

methodsMucormycosis case reports from Türkiye published between 1 January 1966 and 30 November 2024 were reviewed and analyzed, with an emphasis on demographics, clinical characteristics, treatment strategies, and outcomes.

resultsA total of 199 cases from 155 publications were included. Mean age was 47.7 years, and 51.8% of patients were male. Diabetes mellitus was the most frequent underlying condition (65.8%), followed by hematologic malignancies (16.6%). Rhino-cerebral involvement was the predominant clinical form (86.4%). Histopathological confirmation was reported in 91.0% of cases, whereas microbiological confirmation was available in 47.7%. Overall mortality was 43.7%. Surgical debridement was performed in 69.3% of cases, and crude mortality was lower among patients who underwent surgery than among those who did not. Liposomal amphotericin B was the most frequently reported antifungal agent.

conclusionsThis study provides a national descriptive synthesis of published mucormycosis cases from Türkiye over nearly six decades. The findings highlight the predominance of diabetes-associated rhino-cerebral disease, frequent reliance on histopathology, and the importance of combined medical-surgical management in routine practice. Because the dataset is based on heterogeneous published case reports and case series spanning a long time period, treatment-outcome findings should be interpreted descriptively.